|
TMED10P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.14270000004269E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.763700E-02 |
| Stage1-vs-Stage3 |
5.553900E-02 |
| Stage1-vs-Stage4 |
1.159220E-03 |
| Stage2-vs-Stage3 |
9.845900E-04 |
| Stage2-vs-Stage4 |
1.408290E-04 |
| Stage3-vs-Stage4 |
2.206600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.06680000178505E-08 |
| Normal-vs-Asian |
1.68021152546771E-12 |
| Caucasian-vs-AfricanAmerican |
6.685200E-01 |
| Caucasian-vs-Asian |
1.572640E-01 |
| AfricanAmerican-vs-Asian |
6.685400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.861000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63424829224823E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63158375698913E-12 |
| Normal-vs-Age(81-100Yrs) |
1.979850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.522400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.490400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.802600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.956000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.701200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.721600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.25719999977525E-07 |
| Classical-VS-Follicular |
7.098800E-03 |
| Classical-VS-Other |
1.681580E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
4.48399994912307E-09 |
| Tall-VS-Other |
6.693000E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
4.668100E-02 |
| Follicular-VS-Normal |
3.80919999987128E-07 |
| Other-VS-Normal |
2.10800000000066E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.93969318174459E-14 |
| Normal-vs-N1 |
1.11022302462516E-15 |
| N0-vs-N1 |
5.179400E-03 |
|
|
